Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Aging and multiple sclerosis.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Tumefactive demyelination: an approach to diagnosis and management.
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
[Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature.]
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
T-cell trafficking in the central nervous system.
Curcuminoids in Neurodegenerative Diseases.
Control of TH17 cells occurs in the small intestine.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Self-tolerance in multiple sclerosis.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
The effect of intravenous immunoglobulin on neuromyelitis optica.
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.

Pages